Biphenyl-Substituted Oxazolidinones as Cholesteryl Ester Transfer Protein Inhibitors: Modifications of the Oxazolidinone Ring Leading to the Discovery of Anacetrapib

The development of the structure–activity studies leading to the discovery of anacetrapib is described. These studies focused on varying the substitution of the oxazolidinone ring of the 5-aryloxazolidinone system. Specifically, it was found that substitution of the 4-position with a methyl group wi...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 54; no. 13; pp. 4880 - 4895
Main Authors Smith, Cameron J, Ali, Amjad, Hammond, Milton L, Li, Hong, Lu, Zhijian, Napolitano, Joann, Taylor, Gayle E, Thompson, Christopher F, Anderson, Matt S, Chen, Ying, Eveland, Suzanne S, Guo, Qiu, Hyland, Sheryl A, Milot, Denise P, Sparrow, Carl P, Wright, Samuel D, Cumiskey, Anne-Marie, Latham, Melanie, Peterson, Laurence B, Rosa, Ray, Pivnichny, James V, Tong, Xinchun, Xu, Suoyu S, Sinclair, Peter J
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 14.07.2011
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The development of the structure–activity studies leading to the discovery of anacetrapib is described. These studies focused on varying the substitution of the oxazolidinone ring of the 5-aryloxazolidinone system. Specifically, it was found that substitution of the 4-position with a methyl group with the cis-stereochemistry relative to the 5-aryl group afforded compounds with increased cholesteryl ester transfer protein (CETP) inhibition potency and a robust in vivo effect on increasing HDL-C levels in transgenic mice expressing cynomolgus monkey CETP.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
1520-4804
DOI:10.1021/jm200484c